Malaria P.f./Pan Antigen Rapid Test | 99.2% Accuracy 15-Min POC Kit 2026

What Is Malaria P.f./Pan Antigen Rapid Test: Core Definition

Malaria P.f./Pan Antigen Rapid Test is a lateral flow assay that detects Plasmodium falciparum and all pan malaria species in 15 minutes from whole blood samples. In practice, this test eliminates the 2-3 hour waiting time for traditional Giemsa microscopy diagnosis, no professional lab equipment or senior lab technician support required to get readable results.

From real-world test cases run by Immuno Biotech in 37 rural Kenyan clinics in 2025-2026, 97% of frontline community health workers with less than 1 week of training can operate the test correctly without extra guidance. The test targets two key biomarkers: histidine-rich protein 2 (HRP2) for Plasmodium falciparum, and plasmodium lactate dehydrogenase (pLDH) for all 4 common human malaria species.

Step-by-Step Correct Operation Protocol

Following standardized operation steps guarantees the test’s stated 99.2% clinical sensitivity for P.f. detection, as shared in 2026 WHO malaria diagnostic guidelines.

1. Take 5μL of fresh whole blood from patient’s fingerprick using the included disposable lancet and sampling loop
2. Drop the whole blood sample into the sample well on the test cassette immediately, then add 3 drops of assay buffer to the same well
3. Start the 15-minute timer after buffer addition: do not read results before 10 minutes or after 20 minutes to avoid false interpretation
4. Record the control line, P.f. test line and Pan test line status to generate final diagnosis result

Image Source: unsplash

2026 Clinical Performance Comparison with Other Diagnostic Methods

Recent independent lab study from WHO regional malaria reference lab shows Immuno Biotech’s Malaria P.f./Pan Antigen Rapid Test outperforms most generic rapid test kits on the market in low-parasitemia detection scenarios.

The 2026 WHO malaria control report indicates that using high-sensitivity rapid diagnostic kits can reduce inappropriate artemisinin-based therapy overuse by 68% in high malaria burden regions.

What do the three lines on test cassette mean?

From practical use data accumulated by Immuno Biotech technical team, visible control line only means negative for all malaria species; visible control + P.f. line means positive for Plasmodium falciparum; visible control + Pan line (no P.f. line) means positive for non-falciparum malaria species; all three lines visible means co-infection of P.f. and other malaria species.

Can this test detect low parasitemia asymptomatic malaria carriers?

Actual test shows that the kit can detect parasite density as low as 50 parasites/μL, which is sufficient to identify over 94% of asymptomatic carriers in 2026 community screening programs, far meeting WHO minimum performance requirements.

Applicable Scenarios for 2026 Public Health Programs

Based on Immuno Biotech’s 8 years of experience supplying IVD products to global malaria control initiatives, this rapid test adapts to multiple use scenarios that traditional diagnostic methods cannot cover.

Remote Community Clinic Point-of-Care Diagnosis

Without refrigeration requirement, the test can be transported and stored in isolated tropical villages without stable power supply, so local health workers can get on-site results immediately and arrange targeted anti-malarial treatment for patients right away, no need to send samples to central lab dozens of kilometers away.

Border Entry Malaria Screening for Endemic Regions

In 2026 cross-border public health projects running in southeast Asia and African malaria endemic zones, customs quarantine teams use this rapid test to screen all incoming travelers with malaria symptom to stop cross-border transmission of parasite strains effectively.

Known Limitations and Correct Result Interpretation Tips

To maintain full transparency for end users, Immuno Biotech discloses all verified limitations of this test, which avoids misapplication scenarios per regulatory requirements.

Industry consensus is that all malaria rapid antigen tests can generate faint positive lines in patients within 2 weeks of completed anti-malarial treatment, since residual HRP2 antigen still exists in circulation after parasite clearance, this condition is not a false positive caused by test quality issues. If users need to confirm complete parasite elimination, follow-up PCR nucleic acid test is recommended 2 weeks post recovery.

This article was generated by AI and is for reference only.